Behrouz Shademan

Dr. Behrouz Shademan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
NKNilufer Ozdemir Kutbay
Nilufer Ozdemir Kutbay
CACigir Biray Avci
Cigir Biray Avci
BYBanu Sarer Yurekli
Banu Sarer Yurekli
CKCansu Caliskan Kurt
Cansu Caliskan Kurt
BSBehrouz Shademan
Behrouz Shademan
MEMehmet Erdogan
Mehmet Erdogan

2 July 2022 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
BSBehrouz Shademan
Behrouz Shademan
VKVahidreza Karamad
Vahidreza Karamad
ANAlireza Nourazarian
Alireza Nourazarian
SMSepideh Masjedi
Sepideh Masjedi
AIAlireza Isazadeh
Alireza Isazadeh
CACigir Biray Avcı
Cigir Biray Avcı
MicroRNAs are small RNAs with ability to attach to the large number of RNA that regulate gene expression on post-transcriptional level via inhibition or degradation of specific mRNAs. MiRNAs in cells are the primary regulators of functions such as cell growth, differentiation, and apoptosis and considerably influence cell function. The expression levels of microRNAs change in human diseases, including cancer. These changes highlight their essential role in cancer pathogenesis. Ubiquitous irregular expression profiles of miRNAs have been detected in various human cancers using genome-wide identification techniques, which are emerging as novel diagnostic and prognostic cancer biomarkers of high specificity and sensitivity. The measurable miRNAs with enhanced stability in blood, tissues, and other body fluids provide a comprehensive source of miRNA-dependent biomarkers for human cancers. The leading role of miRNAs as potential biomarkers in human cancers is discussed in this article. In addition, the interests and difficulties of miRNAs as biomarkers have been explored.

14 November 2024 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
BDBahar Dehghan
Bahar Dehghan
NANarges Abolhasanzadeh
Narges Abolhasanzadeh
BSBehrouz Shademan
Behrouz Shademan
ANAlireza Nourazarian
Alireza Nourazarian
This review delves into the intricate biological underpinnings of pain perception. It encompasses nociceptive signaling pathways, the molecular mechanisms involved, and the subjective experience of discomfort in humans. The initial focus is on nociceptor transduction, where specialized neurons transform noxious stimuli into electrical impulses. Subsequently, the review explores the central nervous system, elucidating how these signals are processed and modulated by critical elements such as ion channels, receptors, and neurotransmitters (e.g., substance P, glutamate, GABA). Shifting gears toward chronic pain, the review examines the concept of neuroplasticity, highlighting its potential to induce maladaptive responses through alterations in neural networks. The burgeoning field of pain genomics, alongside established genetic research, offers valuable insights that could pave the way for a framework of personalized pain management strategies. Finally, the review emphasizes the significance of these molecular insights in facilitating accurate therapeutic interventions. The overarching objective is to establish an integrative framework for precision medicine in pain management by incorporating this information alongside biopsychosocial models. This framework serves to translate the heterogeneous landscape of pain mechanisms into a coherent roadmap for the development of effective therapies.

22 August 2021 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
BSBehrouz Shademan
Behrouz Shademan
VKVahidreza Karamad
Vahidreza Karamad
ANAlireza Nourazarian
Alireza Nourazarian
CACigir Biray Avcı
Cigir Biray Avcı
Immunotherapy has become a prominent strategy for the treatment of cancer. A method that improves the immune system’s ability to attack a tumor (Enhances antigen binding). Targeted killing of malignant cells by adoptive transfer of chimeric antigen receptor (CAR) T cells is a promising immunotherapy technique in the treatment of cancers. For this purpose, the patient’s immune cells, with genetic engineering aid, are loaded with chimeric receptors that have particular antigen binding and activate cytotoxic T lymphocytes. That increases the effectiveness of immune cells and destroying cancer cells. This review discusses the basic structure and function of CAR-T cells and how antigenic targets are identified to treat different cancers and address the disadvantages of this treatment for cancer.

1 January 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
NKNegin Bodaghi Khajenobar
Negin Bodaghi Khajenobar
SMSoltanali Mahboob
Soltanali Mahboob
ANAlireza Nourazarian
Alireza Nourazarian
BSBehrouz Shademan
Behrouz Shademan
DLDelara Laghousi
Delara Laghousi
MNMasoud Nikanfar
Masoud Nikanfar

1 January 2025 in Advances in Virology
Verified
Journal Article
Open access
ANAlireza Nourazarian
Alireza Nourazarian
HYHadi Yousefi
Hadi Yousefi
CACigir Biray Avci
Cigir Biray Avci
BSBehrouz Shademan
Behrouz Shademan
EBEmad Behboudi
Emad Behboudi
Programmed cell death (PCD) is a well‐studied cellular mechanism that plays a critical role in immune responses, developmental processes, and the maintenance of tissue homeostasis. However, viruses have developed diverse strategies to bypass or manipulate the host apoptotic machinery to enhance their replication and survival. As a result, the interaction between PCD pathways and viruses has garnered increased interest, leading to many studies being published in recent years. This study aims to provide an overview of the current understanding of PCD pathways and their significance in viral infections. We will discuss various forms of cell death pathways, including apoptosis, autophagy, necroptosis, and pyroptosis, as well as their corresponding molecular mechanisms. In addition, we will show how viruses manipulate host PCD pathways to prevent or delay cell death or facilitate viral replication. This study emphasizes the importance of investigating the mechanisms by which viruses control the host’s PCD machinery to gain insight into the evolutionary dynamics of host‐pathogen interactions and to develop new approaches for predicting and managing viral threats. Overall, we aimed to highlight new research areas in PCD and viruses, including introduction of new targets for the development of new antiviral drugs to modulate the cellular apoptotic machinery and novel inhibitors of host cell death pathways.